Literature DB >> 35001223

The association between the type of anesthesia and hemodynamic instability during pheochromocytoma surgery: a retrospective cohort study.

Won Woong Kim1, Doo-Hwan Kim2, Jae Won Cho1, Cheong-Sil Rah3, Yu-Mi Lee1, Ki-Wook Chung1, Jung-Min Koh4, Seung Hun Lee4, Suck Joon Hong3, Yeon Ju Kim5, Tae-Yon Sung6.   

Abstract

BACKGROUND: Pheochromocytoma often carries a risk for perioperative hemodynamic instability (HDI). The aim of this study is to evaluate the risk factors of intraoperative HDI during minimally invasive posterior retroperitoneal adrenalectomy (PRA) for pheochromocytoma.
MATERIALS AND METHODS: This retrospective study analyzed the prospectively collected data of 172 patients who underwent laparoscopic PRA or robotic PRA for pheochromocytoma between January 2014 and December 2020 at a single tertiary center. The patients were divided into two groups according to the intraoperative hypertensive event of systolic blood pressure (> 160 mmHg). The clinical manifestations and perioperative hemodynamic conditions were analysed.
RESULTS: In the multivariate logistic regression analysis, the tumor size (> 3.4 cm) [OR 3.14, 95% confidence intervals (CI) (1.48-6.64), p = 0.003], type of preoperative alpha-blocker (selective type) [OR 3.9, 95% CI (1.52-10.02), p = 0.005], preoperative use of beta-blockers [OR 3.94, 95% CI (1.07-14.49), p = 0.039] and type of anesthesia [total intravenous anesthesia (TIVA) vs. balanced anesthesia (BA)] [OR 2.57, 95% CI (1.23-5.38), p = 0.012] were determined as independent risk factors of intraoperative hypertensive events during minimally invasive adrenalectomy.
CONCLUSIONS: The type of anesthesia was independently associated with intraoperative HDI along with larger tumor size, type of preoperative alpha-blocker and the use of preoperative beta-blockers. TIVA increased the risk of intraoperative hypertensive events compared with BA. Thus, the consideration of the type of anesthesia prior to adrenal surgery for pheochromocytoma along with the use of preoperative non-selective alpha-blockers may be beneficial in minimizing the risk of intraoperative HDI.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Catecholamine; Hemodynamic instability; Pheochromocytoma; Posterior retroperitoneal adrenalectomy

Mesh:

Year:  2022        PMID: 35001223     DOI: 10.1007/s00464-021-08910-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  41 in total

1.  Comparison of transperitoneal laparoscopic versus open adrenalectomy for large pheochromocytoma: A retrospective propensity score-matched cohort study.

Authors:  Song Bai; Zichuan Yao; Xianqing Zhu; Zidong Li; Yunzhong Jiang; Rongzhi Wang; Bin Wu
Journal:  Int J Surg       Date:  2018-11-29       Impact factor: 6.071

2.  The haemodynamic instability score: Development and internal validation of a new rating method of intra-operative haemodynamic instability.

Authors:  Edward Buitenwerf; Mats F Boekel; Marieke I van der Velde; Magiel F Voogd; Michiel N Kerstens; Götz J K G Wietasch; Thomas W L Scheeren
Journal:  Eur J Anaesthesiol       Date:  2019-04       Impact factor: 4.330

3.  Lateral Transperitoneal Adrenalectomy Versus Posterior Retroperitoneoscopic Adrenalectomy for Benign Adrenal Gland Disease: Randomized Controlled Trial at a Single Tertiary Medical Center.

Authors:  Young Jun Chai; Hyeong Won Yu; Ra-Yeong Song; Su-Jin Kim; June Young Choi; Kyu Eun Lee
Journal:  Ann Surg       Date:  2019-05       Impact factor: 12.969

4.  Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades.

Authors:  Margaret Livingstone; Kaylene Duttchen; Jenny Thompson; Zahid Sunderani; Geoffrey Hawboldt; M Sarah Rose; Janice Pasieka
Journal:  Ann Surg Oncol       Date:  2015-03-31       Impact factor: 5.344

5.  The Haemodynamic Instability Score (HIS) for assessment of cardiovascular reactivity in hypertensive and normotensive patients.

Authors:  J E Naschitz; E Sabo; L Gaitini; A Ahdoot; M Ahdoot; N Shaviv; R Musafia-Priselac; I Rosner; S Eldar; D Yeshurun
Journal:  J Hum Hypertens       Date:  2001-03       Impact factor: 3.012

Review 6.  Cardiovascular manifestations of phaeochromocytoma.

Authors:  Aleksander Prejbisz; Jacques W M Lenders; Graeme Eisenhofer; Andrzej Januszewicz
Journal:  J Hypertens       Date:  2011-11       Impact factor: 4.844

7.  Laparoscopic resection of pheochromocytomas with delayed vein ligation.

Authors:  George N Zografos; Athanasios Konstantinos Farfaras; Eva Kassi; Dennis N Vaidakis; Athina Markou; Gregory Kaltsas; George Piaditis
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2011-04       Impact factor: 1.719

Review 8.  Perioperative Management of Pheochromocytoma.

Authors:  Julian Naranjo; Sarah Dodd; Yvette N Martin
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-02-04       Impact factor: 2.628

9.  Predictors of hemodynamic instability during surgery for pheochromocytoma.

Authors:  Colleen M Kiernan; Liping Du; Xi Chen; James T Broome; Chanjuan Shi; Mary F Peters; Carmen C Solorzano
Journal:  Ann Surg Oncol       Date:  2014-06-18       Impact factor: 5.344

10.  Life-threatening events in patients with pheochromocytoma.

Authors:  Anna Riester; Dirk Weismann; Marcus Quinkler; Urs D Lichtenauer; Sandra Sommerey; Roland Halbritter; Randolph Penning; Christine Spitzweg; Jochen Schopohl; Felix Beuschlein; Martin Reincke
Journal:  Eur J Endocrinol       Date:  2015-09-07       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.